Abstract

The MinION sequencer has made in situ sequencing feasible in remote locations. Following our initial demonstration of its high performance off planet with Earth-prepared samples, we developed and tested an end-to-end, sample-to-sequencer process that could be conducted entirely aboard the International Space Station (ISS). Initial experiments demonstrated the process with a microbial mock community standard. The DNA was successfully amplified, primers were degraded, and libraries prepared and sequenced. The median percent identities for both datasets were 84%, as assessed from alignment of the mock community. The ability to correctly identify the organisms in the mock community standard was comparable for the sequencing data obtained in flight and on the ground. To validate the process on microbes collected from and cultured aboard the ISS, bacterial cells were selected from a NASA Environmental Health Systems Surface Sample Kit contact slide. The locations of bacterial colonies chosen for identification were labeled, and a small number of cells were directly added as input into the sequencing workflow. Prepared DNA was sequenced, and the data were downlinked to Earth. Return of the contact slide to the ground allowed for standard laboratory processing for bacterial identification. The identifications obtained aboard the ISS, Staphylococcus hominis and Staphylococcus capitis, matched those determined on the ground down to the species level. This marks the first ever identification of microbes entirely off Earth, and this validated process could be used for in-flight microbial identification, diagnosis of infectious disease in a crewmember, and as a research platform for investigators around the world.

Highlights

  • Technology to enable real-time crew health assessments, including monitoring the environment to which the crew is exposed, is key to the expansion of human space exploration

  • The crew provides an approximation of colony forming units (CFU) to microbiologists at the Johnson Space Center (JSC), offering insight toward microbial load

  • With sights set toward the Moon and Mars, in which regular sample return will be impossible, there is a clear need for an in-flight microbial identification capability

Read more

Summary

Introduction

Technology to enable real-time crew health assessments, including monitoring the environment to which the crew is exposed, is key to the expansion of human space exploration. Genes 2020, 11, 76 microbial environment of the International Space Station (ISS) has been ongoing since its inception [1]. Spaceflight crewmembers collect samples from the station’s air, water, and surfaces onto culture media to promote bacterial and fungal growth. The crew provides an approximation of colony forming units (CFU) to microbiologists at the Johnson Space Center (JSC), offering insight toward microbial load. The identity of the microorganisms is unknown until the samples are returned to Earth for laboratory analysis. With sights set toward the Moon and Mars, in which regular sample return will be impossible, there is a clear need for an in-flight microbial identification capability

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.